title: Cooperation between general practitioners and diabetologists and clinical audit improve the management of type 2 diabetic patients.
abstract: A programme was set up in the Essonne (France) between 1994 and 1998 to improve the quality of care for Type 2 diabetic patients. A consensus panel of general practitioners and diabetes specialists established guidelines based on the French St. Vincent recommendations. An audit involving 73 volunteer general practitioners (out of 965 in the Essonne) then evaluated compliance with these guidelines. Care and outcome were assessed in 505 (1995) and 604 (1996) Type 2 diabetic patients. The first audit cycle showed that defined standards were not met for several criteria and also revealed a lack of standardisation of HbA1c measurements and delayed intervention when blood glucose control was inadequate. Corrective measures were adopted: cooperative protocols for foot care, prevention of nephropathy and retinopathy, standardisation of HbA1c, and an educational programme at the primary health care level. The second audit cycle showed improvement in foot care (+33.6%), quality (+39.9%), prescription of HbA1c (+11.9%), and control of blood pressure (+11.9%) and blood lipids (+12.8%). The proportion of early interventions in case of inadequate glucose control increased significantly (+10.5%). However, some gaps persisted, mainly regarding screening for complications, diet counselling and patient education. This study shows that cooperation between general practitioners and diabetes specialists is feasible and effective in the context of a district-wide approach, and that it facilitates the adoption of international guidelines by local physicians. A project has been developed to provide structured diabetes care in general practice and better access to specialist services in order to improve the outcome of Type 2 diabetic patients.
authors.affiliation: Conseil Départemental du Diabète de l'Essonne, Montgeron, France.
authors.forename: M
authors.initials: M
authors.lastname: Varroud-Vial
authors.forename: P
authors.initials: P
authors.lastname: Mechaly
authors.forename: S
authors.initials: S
authors.lastname: Joannidis
authors.forename: O
authors.initials: O
authors.lastname: Chapiro
authors.forename: S
authors.initials: S
authors.lastname: Pichard
authors.forename: A
authors.initials: A
authors.lastname: Lebigot
authors.forename: M
authors.initials: M
authors.lastname: Moulonguet
authors.forename: C
authors.initials: C
authors.lastname: Attali
authors.forename: A
authors.initials: A
authors.lastname: Bayle
authors.forename: J
authors.initials: J
authors.lastname: Bénier
authors.forename: G
authors.initials: G
authors.lastname: Charpentier
mesh_terms: D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D017719:Diabetic Foot / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000517:prevention & control; D003930:Diabetic Retinopathy / Q000517:prevention & control; D005194:Family Practice; D005215:Fasting; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D008297:Male; D008485:Medical Audit; D008511:Medicine; D008875:Middle Aged; D010353:Patient Education as Topic; D011786:Quality Control; D013038:Specialization
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin